跳至主要内容
临床试验/NCT07209670
NCT07209670尚未招募不适用

Umbilical Venous Versus Peripherally Inserted Central Catheters in Neonates: A Prospective Cohort Study of Complications, Catheter Survival, and CLABSI"

Assiut University0 个研究点目标入组 360 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
360
主要终点
catheter survival time

研究概览

简要总结

This study aims to prospectively compare umbilical venous catheters (UVCs) and peripherally inserted central catheters (PICCs) in neonates, focusing on complications, catheter survival, and central line-associated bloodstream infection (CLABSI) rates

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Days 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Neonates admitted to the neonatal intensive care unit (NICU) requiring central venous access.
  • Infants in whom either an umbilical venous catheter (UVC) or a peripherally inserted central catheter (PICC) was inserted for clinical indications (Parenteral nutrition, administration of intravenous medications (e.g., antibiotics, inotropes, anticonvulsants, fluids) and blood sampling for frequent labs, especially in critically ill neonates).
  • Catheter insertion performed within the first 28 days of life.

排除标准

  • Neonates with major congenital anomalies (e.g.abdominal wall defects) that may interfere with catheter placement or outcomes.
  • Insertion site infection
  • Infants with severe coagulopathy or bleeding disorders contraindicating central catheter insertion.
  • Neonates who received both UVC and PICC simultaneously during the same admission.
  • Cases with incomplete clinical records or missing follow-up data.

结局指标

主要结局

catheter survival time

时间窗: From catheter insertion until removal (up to 28 days of life or until hospital discharge, whichever occurs first)

Number of days each catheter remains functional and in use before removal

Central Line-Associated Bloodstream Infection (CLABSI) Incidence

时间窗: During the entire catheterization period (up to 28 days of life or until hospital discharge

Number of CLABSI events per 1,000 catheter-days, diagnosed according to CDC/NHSN criteria (positive blood culture + clinical signs of sepsis with no other source)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fatma Sayed Ahmed

Principal investigator

Assiut University

相似试验